286 related articles for article (PubMed ID: 23434493)
1. Neuromyelitis optica-like pathology is dependent on type I interferon response.
Khorooshi R; Wlodarczyk A; Asgari N; Owens T
Exp Neurol; 2013 Sep; 247():744-7. PubMed ID: 23434493
[TBL] [Abstract][Full Text] [Related]
2. Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
Felix CM; Levin MH; Verkman AS
J Neuroinflammation; 2016 Oct; 13(1):275. PubMed ID: 27765056
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
Zhang H; Bennett JL; Verkman AS
Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
[TBL] [Abstract][Full Text] [Related]
4. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
6. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of neuromyelitis optica].
Misu T; Fujihara K
Nihon Rinsho; 2013 May; 71(5):823-8. PubMed ID: 23777089
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
[TBL] [Abstract][Full Text] [Related]
10. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Asavapanumas N; Verkman AS
Acta Neuropathol Commun; 2014 Apr; 2():48. PubMed ID: 24758159
[TBL] [Abstract][Full Text] [Related]
12. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica and astrocytic damage in its pathogenesis.
Fujihara K
J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
[TBL] [Abstract][Full Text] [Related]
14. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Saadoun S; Waters P; Bell BA; Vincent A; Verkman AS; Papadopoulos MC
Brain; 2010 Feb; 133(Pt 2):349-61. PubMed ID: 20047900
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
[TBL] [Abstract][Full Text] [Related]
16. Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice.
Li Z; Han J; Ren H; Ma CG; Shi FD; Liu Q; Li M
Front Immunol; 2018; 9():523. PubMed ID: 29616032
[TBL] [Abstract][Full Text] [Related]
17. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathology of multiple sclerosis and neuromyelitis optica].
Masaki K
Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370
[TBL] [Abstract][Full Text] [Related]
19. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
20. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
Zhang H; Verkman AS
J Autoimmun; 2014 Sep; 53():67-77. PubMed ID: 24698947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
